Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (NYSE: ATR) generates news across drug delivery, digital health and consumer dispensing technologies. As a global company serving pharmaceutical, beauty, food, beverage, personal care and home care markets, its announcements often highlight new delivery systems, clinical collaborations, acquisitions and financial updates that are relevant to investors and industry observers.
Recent news has featured Aptar Pharma’s nasal and ophthalmic platforms, such as LuerVax and Spray Divider being used in a Phase II clinical trial of an intranasal COVID-19 vaccine candidate, and Bidose liquid nasal spray systems delivering an FDA-approved treatment for paroxysmal supraventricular tachycardia. The company also reports on developments in eye care, including its Beat the Blink technology and preservative-free multidose dispensers, as well as broader portfolios of ophthalmic solutions.
Aptar’s Digital Health division appears frequently in updates related to connected health tools and data-driven care. Examples include the integration of the Migraine Buddy app with biometric data from wearable devices and FDA 510(k) clearance for HeroTracker Sense, a connected add-on for metered-dose inhalers within a respiratory disease management platform.
Investors following ATR news will also find earnings releases, segment performance commentary, conference participation announcements and information on capital markets activity, such as senior notes offerings. This news page brings together these items so readers can review Aptar’s latest product milestones, partnerships, digital health initiatives and financial communications in one place.
AptarGroup, Inc. (NYSE:ATR) reported a 9% increase in first-quarter sales, reaching $845 million, boosted by double-digit core growth in all segments. Adjusted earnings per share were $0.96, down from $1.05 the previous year, impacted by a higher effective tax rate. The Pharma segment experienced significant growth due to rising demand for allergy and asthma products. Despite operational challenges, including currency headwinds and supply chain issues, the company remains optimistic about future growth. A quarterly dividend of $0.38 was declared, with share repurchases continuing.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, scheduled for payment on May 18, 2022. The record date for shareholders will be April 27, 2022. A conference call to discuss the first quarter results for 2022 is set for April 29, 2022, at 8:00 a.m. Central Time. Aptar is a leader in drug delivery and consumer product dispensing, employing approximately 13,000 individuals across 20 countries.
AptarGroup, Inc. (NYSE: ATR) announces the sad passing of director Jesse Wu, who served on the Board since 2018 and was part of the Management Development & Compensation Committee. The company expresses deep condolences to his family, highlighting Wu's significant contributions, particularly in the Asian market. Aptar is a global leader in drug delivery and consumer product solutions, with 13,000 employees across 20 countries.
AptarGroup, Inc. (NYSE: ATR) has announced a public offering of
Summary not available.
AptarGroup reported robust fourth quarter and annual results for 2021, showcasing a 9% increase in reported sales and a 10% rise in core sales. Annual sales reached a record $3.2 billion, with reported earnings per share climbing 12% to $3.61. The company made strategic acquisitions, including Voluntis and part of Weihai Hengyu Medical Products, enhancing its digital therapeutic and injectable drug delivery capabilities. Despite increased input costs impacting margins, Aptar's commitment to sustainability and cash dividends remains strong, concluding 2021 with $99 million in dividends.
AptarGroup, Inc. (NYSE: ATR) has achieved a Platinum rating from EcoVadis, recognizing its sustainability efforts and placing it in the top 1% of 85,000 companies rated globally. This achievement reflects significant progress from Bronze to Gold and now to Platinum over the last eight years. The rating assesses performance across themes such as environment, labor and human rights, ethics, and sustainable procurement. Aptar’s commitment to sustainability aligns with partners like the Ellen MacArthur Foundation and the United Nations Global Compact.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, payable on February 23, 2022, with a record date of February 3, 2022. The company will host a conference call on February 18, 2022, at 8:00 a.m. CT to discuss its fourth quarter and year-end results for 2021. Additionally, the 2022 Annual Meeting of Stockholders is scheduled for May 4, 2022, at 9:00 a.m. CT, with a record date for voting set for March 11, 2022.
AptarGroup, Inc. (NYSE: ATR) announced the schedule for its quarterly conference calls for the year 2022, with press releases issued after trading hours. Key dates include:
- 4th Quarter and Annual Results: February 17, 2022, with a call on February 18, 2022, at 8:00 a.m. CT
- 1st Quarter Results: April 28, 2022, with a call on April 29, 2022, at 8:00 a.m. CT
- 2nd Quarter Results: July 28, 2022, with a call on July 29, 2022, at 8:00 a.m. CT
- 3rd Quarter Results: October 27, 2022, with a call on October 28, 2022, at 8:00 a.m. CT
Summary not available.